HEPATIC VENO-OCCLUSIVE DISEASE AFTER HIGH-DOSE MITOMYCIN-C AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION THERAPY

被引:44
|
作者
GOTTFRIED, MR
SUDILOVSKY, O
机构
[1] CASE WESTERN RESERVE UNIV, INST PATHOL, CLEVELAND, OH 44106 USA
[2] UNIV HOSP CLEVELAND, CLEVELAND, OH 44106 USA
关键词
D O I
10.1016/S0046-8177(82)80008-7
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
引用
收藏
页码:646 / 650
页数:5
相关论文
共 50 条
  • [11] Hepatic veno-occlusive disease in children undergoing bone-marrow transplantation: usefulness of sonographic findings
    M. B. McCarville
    F. A. Hoffer
    S. C. Howard
    O. Goloubeva
    W. M. Kauffman
    Pediatric Radiology, 2001, 31 : 102 - 105
  • [12] Hepatic veno-occlusive disease in children undergoing bone-marrow transplantation: usefulness of sonographic findings
    McCarville, MB
    Hoffer, FA
    Howard, SC
    Goloubeva, O
    Kauffman, WM
    PEDIATRIC RADIOLOGY, 2001, 31 (02) : 102 - 105
  • [13] Orthotopic liver transplantation for veno-occlusive disease complicating autologous bone marrow transplantation
    Norris, S
    Crosbie, O
    McEntee, G
    Traynor, O
    Nolan, N
    McCann, S
    Hegarty, J
    TRANSPLANTATION, 1997, 63 (10) : 1521 - 1524
  • [14] HIGH-DOSE MITOMYCIN-C WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN PATIENTS WITH REFRACTORY MALIGNANCIES - INFLUENCE OF DOSE SCHEDULE ON PHARMACOKINETICS AND NONHEMATOPOIETIC TOXICITIES
    KARANES, C
    RATANATHARATHORN, V
    SCHILCHER, RB
    YOUNG, JD
    EMMER, D
    HOSCHNER, JA
    LEICHMAN, L
    BAKER, LH
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1986, 9 (05): : 444 - 448
  • [15] Hepatic artery velocity in diagnosis of hepatic veno-occlusive disease after bone marrow transplantation in children
    Kaya, N.
    Erbey, F.
    Atay, D.
    Akcay, A.
    Ozturk, G.
    BONE MARROW TRANSPLANTATION, 2015, 50 : 5582 - 5582
  • [16] Cytokines in veno-occlusive disease of the liver after bone marrow transplantation
    Remberger, M
    Ringden, O
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (06) : 3533 - 3534
  • [17] Incidence and predictive factors of hepatic veno-occlusive disease after bone marrow transplantation.
    Deliliers, GL
    Della Volpe, A
    Bamonti, F
    Deliliers, DL
    Onida, F
    Annaloro, C
    Soligo, D
    BONE MARROW TRANSPLANTATION, 1999, 23 : S223 - S223
  • [18] Escalation to High-Dose Defibrotide in Patients with Hepatic Veno-Occlusive Disease
    Triplett, Brandon M.
    Kuttab, Hani I.
    Kang, Guolian
    Leung, Wing
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (12) : 2148 - 2153
  • [19] VENO-OCCLUSIVE DISEASE OF THE LIVER AFTER BONE-MARROW TRANSPLANTATION - DIAGNOSIS, INCIDENCE, AND PREDISPOSING FACTORS
    MCDONALD, GB
    SHARMA, P
    MATTHEWS, DE
    SHULMAN, HM
    THOMAS, ED
    HEPATOLOGY, 1984, 4 (01) : 116 - 122
  • [20] Does high-dose intravenous immune globulin treatment after bone marrow transplantation increase mortality in veno-occlusive disease of the liver?
    Klaesson, S
    Ringden, O
    Ljungman, P
    Aschan, J
    Hagglund, H
    Winiarski, J
    TRANSPLANTATION, 1995, 60 (11) : 1225 - 1230